Health-care companies rose after a round of generally strong earnings.

Pfizer shares rose after the drug giant said strong cancer-drug sales offset weakness elsewhere.

BioNTech plans to shrink its workforce and manufacturing network, as the German biotech company seeks to regain its footing following a drop in demand for Covid-19 vaccines.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

05-05-26 1717ET